Academic · Private company
Sarcoma Oncology Research Center, LLC
Track this companyFree. Adds Sarcoma Oncology Research Center, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials96 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials9
- Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid TumorsPHASE2 · RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07671534 · fetched Nov 12, 2026
- Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell CulturesWITHDRAWN · started Jan 27, 2023ClinicalTrials.gov NCT05869994 · fetched Nov 12, 2026
- Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue SarcomaPHASE2 · RECRUITING · started Sep 9, 2021ClinicalTrials.gov NCT04535271 · fetched Nov 12, 2026
- GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced SarcomaPHASE2 · UNKNOWN · started Sep 30, 2020ClinicalTrials.gov NCT04535713 · fetched Nov 12, 2026
- SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for SarcomaPHASE2 · ACTIVE_NOT_RECRUITING · started Jan 3, 2020ClinicalTrials.gov NCT03778996 · fetched Nov 12, 2026
- Evaluation of AL3818 in Combination With Nivolumab in Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 17, 2019ClinicalTrials.gov NCT04165330 · fetched Nov 12, 2026
- Talimogene Laherparepvec, Nivolumab and Trabectedin for SarcomaPHASE2 · RECRUITING · started May 15, 2019ClinicalTrials.gov NCT03886311 · fetched Nov 12, 2026
- Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersPHASE1_PHASE2 · COMPLETED · started Aug 24, 2017ClinicalTrials.gov NCT03190174 · fetched Nov 12, 2026
- SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue SarcomaPHASE1_PHASE2 · RECRUITING · started Apr 13, 2017ClinicalTrials.gov NCT03138161 · fetched Nov 12, 2026